In Vitro Anti-Oxidant, In Vivo Anti-Hyperglycemic, and Untargeted Metabolomics-Aided-In Silico Screening of Macroalgae Lipophilic Extracts for Anti-Diabetes Mellitus and Anti-COVID-19 Potential Metabolites
-
Published:2023-11-27
Issue:12
Volume:13
Page:1177
-
ISSN:2218-1989
-
Container-title:Metabolites
-
language:en
-
Short-container-title:Metabolites
Author:
Sunarwidhi Anggit Listyacahyani12, Rahmaniar Wahyu3, Prasedya Eka Sunarwidhi24, Padmi Hasriaton2, Widyastuti Sri5, Pangestu Kukuh Waseso Jati2ORCID, Ilhami Bq Tri Khairina2ORCID, Handayani Ervina1, Utami Ni Wayan Putri1, Maulana Farreh Alan1, Ichfa Muhammad Syach Maulad1, Hernawan Ari6
Affiliation:
1. Department of Pharmacy, Faculty of Medicine, University of Mataram, Mataram 83115, Indonesia 2. Bioscience and Biotechnology Research Centre, University of Mataram, Mataram 83115, Indonesia 3. Institute of Innovative Research, Tokyo Institute of Technology, Yokohama 226-8503, Japan 4. Department of Biology, Faculty of Mathematics and Natural Sciences, University of Mataram, Mataram 83115, Indonesia 5. Faculty of Food Technology and Agroindustry, University of Mataram, Mataram 83115, Indonesia 6. Department of Informatics Engineering, Faculty of Engineering, University of Mataram, Mataram 83115, Indonesia
Abstract
COVID-19 patients with comorbid DM face more severe outcomes, indicating that hyperglycemic conditions exacerbate SARS-CoV-2 infection. Negative side effects from existing hyperglycemia treatments have urged the need for safer compounds. Therefore, sourcing potential compounds from marine resources becomes a new potential approach. Algal lipids are known to possess beneficial activities for human health. However, due to limitations in analyzing large amounts of potential anti-hyperglycemic and anti-COVID-19-related marine metabolites, there is an increasing need for new approaches to reduce risks and costs. Therefore, the main aim of this study was to identify potential compounds in macroalgae Sargassum cristaefolium, Tricleocarpa cylindrica, and Ulva lactuca lipophilic extracts for treating DM and COVID-19 by an integrated approach utilizing in vitro anti-oxidant, in vivo anti-hyperglycemic, and metabolomic-integrated in silico approaches. Among them, S. cristaefolium and T. cylindrica showed potential anti-hyperglycemic activity, with S. cristaefolium showing the highest anti-oxidant activity. A GC-MS-based untargeted metabolomic analysis was used to profile the lipophilic compounds in the extracts followed by an in silico molecular docking analysis to examine the binding affinity of the compounds to anti-DM and anti-COVID-19 targets, e.g., α-amylase, α-glucosidase, ACE2, and TMPRSS2. Notably, this study reveals for the first time that steroid-derived compounds in the macroalgae T. cylindrica had higher binding activity than known ligands for all the targets mentioned. Studies on drug likeliness indicate that these compounds possess favorable drug properties. These findings suggest the potential for these compounds to be further developed to treat COVID-19 patients with comorbid DM. The information in this study would be a basis for further in vitro and in vivo analysis. It would also be useful for the development of these candidate compounds into drug formulations.
Funder
Indonesian Ministry of Education, Culture, Research, and Technology Penelitian Dasar Kompetitif Nasional (PDKN) Scheme
Subject
Molecular Biology,Biochemistry,Endocrinology, Diabetes and Metabolism
Reference96 articles.
1. Investigation of the Effects of COVID-19 on Different Organs of the Body;Birman;Eurasian J. Chem. Med. Pet. Res.,2022 2. Clinical characteristics and outcomes of patients with severe COVID-19 with diabetes;Yan;BMJ Open Diabetes Res. Care,2020 3. Shevchuk, O., Park, A., Palii, S., Ivankiv, Y., Kozak, K., Korda, M., and Vari, S.G. (2023). Blood ACE2 protein level correlates with COVID-19 severity. Int. J. Mol. Sci., 24. 4. Diabetes, infection risk and COVID-19;Erener;Mol. Metab.,2020 5. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?;Fang;Lancet Respir. Med.,2020
|
|